RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma
Mingzhi Zhang(Chinese Academy of Sciences), Ken H. Young(Duke Medical Center), Michael Møller(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Benjamin M. Parsons(Gundersen Health System), Maurilio Ponzoni(San Raffaele University of Rome), Eric D. Hsi(Mayo Clinic), J. Han van Krieken(Radboud University Nijmegen), Zijun Y. Xu‐Monette(Duke University), Attilio Orazi(Texas Tech University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Kristy L. Richards(University of North Carolina at Chapel Hill), April Chiu(Mayo Clinic), Youli Zu(Methodist Hospital), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Santiago Montes‐Moreno(Universidad de Cantabria), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Jooryung Huh(Asan Medical Center), Jing Wang(Naval Medical Research Command), William W.L. Choi(Chinese University of Hong Kong), Ling Li(First Affiliated Hospital of Zhengzhou University), L. Jeffrey Medeiros(Delaware Division of Libraries), Lan V. Pham(Pharmacyclics (United States)), Jane N. Winter(Northwestern University)
Cited by 39
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k